Dosidal · Switzerland
Rifampicine Labatec, gélules
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:50264 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 50264 atc: J04AB02 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 1989-08-11 term: zugelassen valid_until: 9999-12-31 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: J04AB02 authorisation_number: 50264 form: KAHA holder: Labatec Pharma SA holder_partner_nr: 1000310 it_number: 08.02.1. name: Rifampicine Labatec, gélules state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53ovhigJig-cnLopeRlF4YF2V81h7xDy3kqH5LiVXGxKzpfnMwCiXv3i8m94zmiruMUaMV_Ofio2ucHn2okTKdJwVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/ch:authorisation:50264 · Related records in other markets · Dosidal